07.27.26 -- The Hidden Supply Chain Bottlenecks Threatening Pipelines

Gain insights into how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.

Review strategies to strengthen global biologics manufacturing through consistent quality, advanced technologies, and efficient tech transfer to improve operations and commercial readiness.

How do you maintain supply continuity amid geopolitical risk? Learn how a large-scale process was requalified in just eight months to protect a clinical biologics program.

Modular single-use facility design — combining closed processing and global standards — boosts flexibility, speeds tech transfer, and strengthens supply resilience in modern biomanufacturing networks.

Discover how a proactive, risk-based supply chain strategy can help strengthen resilience, mitigate disruption, and ensure continuity across your biotech and pharmaceutical operations.

Biologics development leaders discuss industry challenges, including innovation pressures, operational complexity, leadership decisions, and maintaining quality and resilience in an evolving landscape.

Struggling to optimize CHO cell line development? Assess how increased glutamine synthetase selection stringency and a high-strength promoter can improve gene expression control.

Learn how this advanced strategy accelerates development timelines while delivering consistently high titers, robust manufacturability, and enhanced product quality.

Early collaboration with an expert partner streamlines HME projects through optimized formulation, strong scale‑up, solid analytics, and adaptable technologies that boost performance.

Dive into the scope of <382> for pharmaceutical closures and the regulatory landscape, which includes new required tests, instrumentation for compliance, and recommendations on implementation.

See how a CDMO with extensive experience in protein variant characterization, CQA analytics, and patient-centric product development can ensure the safety and efficacy of your biotherapeutic.

Review studies that involve scaling down individual process steps, and for each step, spiking virus into the specific process intermediate, performing the process step, and measuring the remaining virus.